The Swiss biopharma company said the deal with the German National Association of Statutory Health Insurance Funds (GKV-SV) ...
Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by the problem pathogen Escherichia coli looks ...
Marci English, head of biopharma and ophthalmology development at Astellas Pharma, said the FDA's change of heart will ...
The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with two PharmaLex experts about navigating complex R&D ...
They also discovered that cigarette use declined among a subgroup of smokers in the study, lending weight to the hypothesis ...
Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...
The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics and machine learning company Zymergen (bought by Ginkgo Bioworks in 2022), ...
Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the ...
Recognising that challenge, AstraZeneca's rare disease unit Alexion has launched an interactive storybook that can help ...
The downsizing of health federal agencies comes after Trump threatened to pull the US out of the World Health Organization ...
The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...